May 2 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX
* Department of health designated scenesse to be evaluated as a highly specialised technology Source text for Eikon: ID:nASX97XJLh Further company coverage: CUV.AX
May 2 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX
* Department of health designated scenesse to be evaluated as a highly specialised technology Source text for Eikon: ID:nASX97XJLh Further company coverage: CUV.AX